Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Synthetic biodegradable polymers as orthopedic devices

John Middleton, Arthur James Tipton · Biomaterials · 2000 · 2.7K citations

Natural Sciences, Orthopaedic Surgery, Orthopedic Surgery +14

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

Gregg W. Stone · JAMA · 2008 · 584 citations

Medicine, Cardiology, Pharmacotherapy +15

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 560 citations · Full text

Medicine, Cardiology, Surgery +17

Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds

Serban Puricel, Diego Arroyo, Noé Corpataux et al. · Journal of the American College of Cardiology · 2015 · 200 citations

Medicine, Biomedical Engineering, Cardiology +14